INVO Bioscience Inc (INVO)

[shorthound]

Hollywood, I am not aware of any stock price cap for an OTC stock.

As far as where would I sell, it's too early to say. We don't have enough data as to estimate a stock price. We don't know anything about their franchise deals, partnerships, product pricing, etc.

We are just learning they have almost doubled the number of clinics where the INVOcell product will be available and that is definitely good news but still not enough data. Again, this is not a quick trade for me, your timeframe may be different.

Also, I would err on caution. I'm not one to give ridiculous price targets based on hot air or dubious claims of impending buyouts which several people did leading up to the FDA clearance and after. Regardless you would have to be a fool to believe any of these claims for the same reason we have today, the company is not fully reporting so any of those claims were just speculation.

I'm fairly certain there are bagholders based on those claims but they only have themselves to blame for that. I think at one point I stated that I thought it could get to the $1 or $2 at most (it hit $1.49) range but others were claiming $5 or more. I said then that it was dangerous to make those claims based on nothing more than supposed "buy out claims". I even showed other stocks that had been approved moved about 20% or so and that huge gains were not likely.

I know I'm not giving you what you want but hope this helps in some way.